Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Studies have shown that a GLP-1 drug, exenatide, sufficiently crosses the blood-brain barrier in rodent models of Parkinsons disease, leading to improvements in motor performance, behavior, learning and memory
When two substances with similar physiological effects are taken concurrently, their combined impact can be greater than either taken alone
It simultaneously activates GLP-1 and GIP receptors, hormones naturally produced in the body that regulate appetite, metabolism, and blood sugar
Effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors on cardiorenal and metabolic outcomes in people without diabetes
US$ 22.23
US$ 29.41
US$ 25.92
US$ 25.04
